RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION

RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION

Aim. To assess effectiveness and safety of the hospital use of recombinant non-immunogenic staphylokinase in patients with acute ST-elevated myocardial infarction (STEMI).Material and methods. Recombinant non-immunogenic staphylokinase was administered during in-hospital stage of treatment of 93 pa...

Full description

Saved in:

Bibliographic Details
Main Author:	V. B. Kostogryz
Format:	Article
Language:	English
Published:	Столичная издательская компания 2017-03-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	acute st-elevated myocardial infarction thrombolytic therapy recombinant non-immunogenic staphylokinase
Online Access:	https://www.rpcardio.online/jour/article/view/1416
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE
by: E. S. Mazur, et al.
Published: (2017-09-01)

Clinical case of the non-immunogenic recombinant staphylokinase usage in the treatment of massive pulmonary embolism in patient with genetically determined thrombophilia
by: G. D. Azizova, et al.
Published: (2025-04-01)

Assessment of the allergenic and immunotoxic properties of the recombinant non-immunogenic staphylokinase in preclinical and clinical trials
by: S. S. Markin, et al.
Published: (2025-07-01)

Non-immunogenic staphylokinase — a thrombolytic agent in the treatment of massive pulmonary embolism: results of the FORPE clinical trial
by: A. I. Kirienko, et al.
Published: (2024-12-01)

The Safety of Non‐immunogenic Recombinant Staphylokinase in Elderly Patients With Massive Pulmonary Embolism: A Randomized Clinical Trial FORPE
by: Stanislav G. Leontyev, et al.
Published: (2025-05-01)

Coronary angiographic assessment of streptokinase efficacy in young patients with ST-elevation myocardial infarction
by: Chetan Solanki, et al.
Published: (2025-02-01)

Primary angioplasty and pharmaco-invasive strategies in the treatment of ST-elevated myocardial infarction
by: M. G. Glezer, et al.
Published: (2019-04-01)

Clinical features of the acute period of myocardial infarction with ST segment elevation in patients after reperfusion therapy
by: S. M. Kyselov, et al.
Published: (2020-10-01)

Non-immunogenic staphylokinase in the high-risk pulmonary embolism treatment with subdural hematoma
by: S. L. Konstantinov, et al.
Published: (2025-08-01)

ST-segment elevation myocardial infarction and the clinical significance of differentiated electrocardiogram
by: V. K. Tashchuk, et al.
Published: (2023-05-01)

Relationship of ST-segment elevation myocardial infarction with weather and season
by: Okkes Zortuk, et al.
Published: (2024-04-01)

In-hospital outcomes of ST elevation myocardial infarction in post-COVID-19 patients
by: M. G. Chashchin, et al.
Published: (2023-03-01)

RISKS AND BENEFITS OF REPERFUSION STRATEGIES IN ACUTE MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION
by: T. M. Poponina, et al.
Published: (2010-10-01)

LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION
by: N. E. Zakirova, et al.
Published: (2016-05-01)

CORONARY REPERFUSION IN ST ELEVATION MYOCARDIAL INFARCTION: PROBLEMS AND SOLUTIONS
by: V. A. Markov, et al.
Published: (2015-01-01)

Short-term exposure to ambient air pollution increased in-hospital non-ST-elevation myocardial infarction mortality risk, but not ST-elevation myocardial infarction: case-crossover based evidence from Beijing, China
by: Yakun Zhao, et al.
Published: (2025-06-01)

EFFECT OF GENDER DIFFERENCES ON THE EFFICACY AND SAFETY OF REPERFUSION THERAPY OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (DATA OF RETROSPECTIVE SINGLE-CENTER STUDY – HOSPITAL PERIOD)
by: D. B. Nemik, et al.
Published: (2016-06-01)

Early Readmissions After ST‐Segment–Elevation Myocardial Infarction: Glass Ceiling or Room for Improvement?
by: Beau M. Hawkins, et al.
Published: (2018-09-01)

2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction
by: (RSC) Russian Society of Cardiology
Published: (2020-12-01)

THE RELEVANCE OF THROMBOLYTIC THERAPY IN ST ELEVATION MYOCARDIAL INFARCTION
by: N. V. Teplova, et al.
Published: (2014-05-01)

Double Culprits in a Patient with ST Elevation Myocardial Infarction: A Challenging But Rewarding Case
by: Eka Ginanjar, et al.
Published: (2018-06-01)

Double Culprits in a Patient with ST Elevation Myocardial Infarction: A Challenging But Rewarding Case
by: Eka Ginanjar, et al.
Published: (2018-06-01)

Short-Term Exposure to Air Pollution Associated with an Increased Risk of ST-Elevation and Non-ST-Elevation Myocardial Infarction Hospital Admissions: A Case-Crossover Study from Beijing (2013–2019), China
by: Yakun Zhao, et al.
Published: (2025-06-01)

Genetic markers of risk for ST-elevated myocardial infarction
by: N. G. Lozhkina, et al.
Published: (2019-11-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
by: O. V. Reshetko, et al.
Published: (2016-01-01)

Non-immunogenic staphylokinase in the treatment of high-risk massive pulmonary embolism in the early postoperative period due to femoral fragment wound
by: S. L. Konstantinov, et al.
Published: (2023-11-01)

ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: D. B. Nemik, et al.
Published: (2018-07-01)

Reassess Hospital Costs and Mortality Between Myocardial Infarction With and Without ST‐Segment Elevation in a Modern Context
by: Honglan Ma, et al.
Published: (2024-11-01)

Biventricular dysfunction predicts mortality in ST elevation myocardial infarction patients with cardiogenic shock
by: Angga Dwi Prasetyo, et al.
Published: (2025-01-01)

Non-ST-elevation myocardial infarction: dual etiology, twoway therapy
by: Mihály Medvegy, et al.
Published: (2025-07-01)

The feasibility of Kimny guiding catheter for ST-segment elevation myocardial infarction
by: Sou-Chan Tsai, et al.
Published: (2022-01-01)

Prevalence of Risk Factors of Acute Coronary Syndrome in Erbil Cardiac Center: comparing ST-elevation with non ST-elevation Acute Coronary Syndrome
by: Omar Hama Radha Qader, et al.
Published: (2024-03-01)

EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Relationship Between Infarct Artery, Myocardial Injury, and Outcomes After Primary Percutaneous Coronary Intervention in ST‐Segment–Elevation Myocardial Infarction
by: Suzanne de Waha, et al.
Published: (2024-09-01)

Prospects for a pharmacoinvasive strategy in ST-elevation myocardial infarction in the Russian Federation
by: V. E. Oleynikov, et al.
Published: (2025-04-01)

Examining the Specificity of Smartphone ECG Devices in Decision-Making for ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction
by: Sahil mahajan, et al.
Published: (2025-01-01)

Annual personalised calculator for prognostication after ST-segment elevation myocardial infarction
by: V. B. Barbarich, et al.
Published: (2020-06-01)

Non-immunogenic staphylokinase in patients with massive intermediate-high risk pulmonary embolism: protocol of the FORPE-2 multicenter, double-blind, randomized, placebo-controlled trial
by: S. N. Tereshchenko, et al.
Published: (2025-03-01)

RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD)
by: D. B. Nemick, et al.
Published: (2015-12-01)

Dynamics of leukocyte inflammatory markers in patients with ST-elevation myocardial infarction depending on left ventricle ejection fraction
by: V. K. Tashchuk, et al.
Published: (2023-01-01)